ADOCY (Adocia) 9-Day RSI: N/A (As of Jul. 05, 2026)


ADOCY Adocia ADOCY
37 GF Score
Price $11.80
GF Value $2.38
! 7 Warning Signs
View Full Analysis

What is Adocia 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-05), Adocia's 9-Day RSI is N/A.

The industry rank for Adocia's 9-Day RSI or its related term are showing as below:

ADOCY's 9-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 53.73
* Ranked among companies with meaningful 9-Day RSI only.

Adocia  (OTCPK:ADOCY) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

Adocia 9-Day RSI Related Terms

ADOCY vs VRTX, REGN, ALNY: 9-Day RSI Comparison

For the Biotechnology subindustry, Adocia's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adocia 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adocia's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Adocia's 9-Day RSI falls into.


ADOCY
37GF Score
Adocia ADOCY
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adocia  (OTCPK:ADOCY) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Adocia (ADOCY) Overvalued in 2026?

Based on GuruFocus' analysis, Adocia stock appears to be overvalued. The current stock price of $11.80 is trading 395.8% above its estimated GF Value™ of $2.38.

Key valuation signals for ADOCY:

  • 9-Day RSI: N/A
  • GF Value™: $2.38 vs. price of $11.80 (395.8% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the ADOCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adocia Business Description

Address 115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
37GF Score

Get the complete analysis for ADOCY

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.80
Price
$2.38
GF Value